Adagio Medica announced that the company’s chief business officer, Deborah Kaster’s, responsibilities have been expanded to include the role of CFO, effective September 5. Kaster succeeds Dan George, who served as the company’s interim CFO since April. In this enhanced position as CFO and CBO, Kaster will continue to oversee business development, corporate strategy and investor relations while assuming responsibility for the company’s financial operations, including accounting, treasury, and financial planning. Kaster will continue to report to Todd Usen, CEO of Adagio.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADGM:
